1. Home
  2. KHC vs IQV Comparison

KHC vs IQV Comparison

Compare KHC & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$23.73

Market Cap

27.8B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$191.19

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KHC
IQV
Founded
1869
1982
Country
United States
United States
Employees
35000
93000
Industry
Packaged Foods
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8B
28.6B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
KHC
IQV
Price
$23.73
$191.19
Analyst Decision
Hold
Strong Buy
Analyst Count
17
16
Target Price
$24.50
$227.13
AVG Volume (30 Days)
13.0M
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
7.14%
N/A
EPS Growth
N/A
4.67
EPS
0.67
1.61
Revenue
$24,942,000,000.00
$9,739,000,000.00
Revenue This Year
N/A
$6.77
Revenue Next Year
$0.58
$5.89
P/E Ratio
$35.03
$115.64
Revenue Growth
N/A
41.60
52 Week Low
$21.04
$154.50
52 Week High
$29.19
$247.05

Technical Indicators

Market Signals
Indicator
KHC
IQV
Relative Strength Index (RSI) 53.48 61.95
Support Level $23.30 $159.91
Resistance Level $24.51 $191.20
Average True Range (ATR) 0.57 6.50
MACD -0.04 0.61
Stochastic Oscillator 66.94 92.85

Price Performance

Historical Comparison
KHC
IQV

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: